On the other hand, bFGF has also shown the opposite effect and sensitizes breast, prostate, ovarian and pancreatic cancer cells to different chemotherapeutic agents including cisplatin, etoposide, 5-fluorouracil, doxorubicin, carboplatin, and docetaxel [7]. This evidence concerns the gene FGF2 and pancreatic neoplasm.